Ofotokun I - Search Results

1

The protease inhibitors and HIV-associated bone loss.

Moran CA, Weitzmann MN, Ofotokun I. Moran CA, et al. Among authors: ofotokun i. Curr Opin HIV AIDS. 2016 May;11(3):333-42. doi: 10.1097/COH.0000000000000260. Curr Opin HIV AIDS. 2016. PMID: 26918650 Free PMC article. Review.

2

Sex differences in the pharmacologic effects of antiretroviral drugs: potential roles of drug transporters and phase 1 and 2 metabolizing enzymes.

Ofotokun I. Ofotokun I. Top HIV Med. 2005 Jun-Jul;13(2):79-83. Top HIV Med. 2005. PMID: 16082059 Free article. Review.

3

Liver enzymes elevation and immune reconstitution among treatment-naïve HIV-infected patients instituting antiretroviral therapy.

Ofotokun I, Smithson SE, Lu C, Easley KA, Lennox JL. Ofotokun I, et al. Am J Med Sci. 2007 Nov;334(5):334-41. doi: 10.1097/MAJ.0b013e31811ec780. Am J Med Sci. 2007. PMID: 18004087 Free PMC article.

4

Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats.

Vikulina T, Fan X, Yamaguchi M, Roser-Page S, Zayzafoon M, Guidot DM, Ofotokun I, Weitzmann MN. Vikulina T, et al. Among authors: ofotokun i. Proc Natl Acad Sci U S A. 2010 Aug 3;107(31):13848-53. doi: 10.1073/pnas.1003020107. Epub 2010 Jul 19. Proc Natl Acad Sci U S A. 2010. PMID: 20643942 Free PMC article.

5

HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture.

Ofotokun I, Weitzmann MN. Ofotokun I, et al. Curr Opin Endocrinol Diabetes Obes. 2010 Dec;17(6):523-9. doi: 10.1097/MED.0b013e32833f48d6. Curr Opin Endocrinol Diabetes Obes. 2010. PMID: 20844427 Free PMC article. Review.

6

HIV and bone metabolism.

Ofotokun I, Weitzmann MN. Ofotokun I, et al. Discov Med. 2011 May;11(60):385-93. Discov Med. 2011. PMID: 21616037 Free PMC article. Review.

7

HIV: inflammation and bone.

Ofotokun I, McIntosh E, Weitzmann MN. Ofotokun I, et al. Curr HIV/AIDS Rep. 2012 Mar;9(1):16-25. doi: 10.1007/s11904-011-0099-z. Curr HIV/AIDS Rep. 2012. PMID: 22179898 Free PMC article. Review.

8

Dysregulated B cell expression of RANKL and OPG correlates with loss of bone mineral density in HIV infection.

Titanji K, Vunnava A, Sheth AN, Delille C, Lennox JL, Sanford SE, Foster A, Knezevic A, Easley KA, Weitzmann MN, Ofotokun I. Titanji K, et al. Among authors: ofotokun i. PLoS Pathog. 2014 Nov 13;10(10):e1004497. doi: 10.1371/journal.ppat.1004497. eCollection 2014 Oct. PLoS Pathog. 2014. PMID: 25393853 Free PMC article.

9

Impact of protease inhibitors on intracellular concentration of tenofovir-diphosphate among HIV-1 infected patients.

Lahiri CD, Tao S, Jiang Y, Sheth AN, Acosta EP, Marconi VC, Armstrong WS, Schinazi RF, Vunnava A, Sanford S, Ofotokun I. Lahiri CD, et al. Among authors: ofotokun i. AIDS. 2015 Jun 1;29(9):1113-5. doi: 10.1097/QAD.0000000000000659. AIDS. 2015. PMID: 25870991 Free PMC article.

10

Cerebrospinal fluid concentrations of tenofovir and emtricitabine in the setting of HIV-1 protease inhibitor-based regimens.

Lahiri CD, Reed-Walker K, Sheth AN, Acosta EP, Vunnava A, Ofotokun I. Lahiri CD, et al. Among authors: ofotokun i. J Clin Pharmacol. 2016 Apr;56(4):492-6. doi: 10.1002/jcph.612. Epub 2015 Oct 20. J Clin Pharmacol. 2016. PMID: 26247878 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

208 results

Search Page